论文部分内容阅读
目的探析社区高血压患者用非洛地平缓释片治疗对其病情改善作用及药物安全性。方法一般资料来自本社区2014年-2016年期间门诊就诊治疗的高血压患者,于该群体中随机抽取80例并通过随机数字表方式将患者每组40例分为对照组(常规治疗)和观察组(联合非洛地平缓释片治疗),了解两种治疗方案下患者血压指标控制以及不良反应情况。结果根据患者血压指标判断疗效,观察组判定无效例数明显低于对照组,组间总有效率统计学软件处理提示有意义(P<0.05);观察组发生药物不良反应例数5例,对照组出现不良反应例数10例,组间统计学软件处理,提示有意义(P<0.05)。结论对社区高血压患者在常规治疗基础上联合非洛地平缓释片干预对于患者高血压指标控制令人满意,同时治疗期间药物安全性高,值得临床推广。
Objective To explore the effect of improving the condition of patients with community-based hypertensive patients treated with sustained-release tablets of felodipine and the drug safety. Methods General information was obtained from outpatients with hypertension in our community from 2014 to 2016. Eighty patients were randomized in this community and 40 patients in each group were divided into control group (routine treatment) and observation by random number table Group (combined with Felodipine extended release tablets treatment), understand the two kinds of treatment options in patients with blood pressure control and adverse reactions. Results According to the patient’s blood pressure index, the number of invalid cases in the observation group was significantly lower than that in the control group. Statistical analysis indicated that the total effective rate was statistically significant (P <0.05). The number of adverse drug reactions in the observation group was 5 cases, Group of adverse reactions occurred in 10 cases, statistical software between groups, suggesting a significant (P <0.05). Conclusion The control of hypertension in patients with hypertension in community based on conventional treatment combined with sustained-release tablets of felodipine is satisfying. At the same time, the drug safety during treatment is high and worthy of clinical promotion.